Serum and Tear Levels of Nerve Growth Factor in Diabetic Retinopathy Patients
Authors:
- Sung Soo KimSKSung Soo Kim
- Hyeon Chang KimHKHyeon Chang Kim
- Chul Woo AhnCAChul Woo Ahn
- Hyung Keun LeeHLHyung Keun Lee
- 1 March 2008
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 145 (3) , 432-437
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Nerve Growth Factor Concentration and Implications in Photorefractive Keratectomy vs Laser In Situ KeratomileusisAmerican Journal of Ophthalmology, 2005
- Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic miceDiabetologia, 2004
- Diabetic RetinopathyNew England Journal of Medicine, 2004
- Nerve growth factor–endothelial cell interaction leads to angiogenesis in vitro and in vivoThe FASEB Journal, 2002
- Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factorsProceedings of the National Academy of Sciences, 2001
- Altered Plasma Levels of Nerve Growth Factor and Transforming Growth Factor-β2 in Type-1 Diabetes MellitusBrain, Behavior, and Immunity, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Nerve growth factor: from neurotrophin to neurokineTrends in Neurosciences, 1996
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs—An Extension of the Modified Airlie House ClassificationOphthalmology, 1991